数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
James R. Andrews Director 74 未披露 未持股 2017-09-11
Scott M. W. Haufe Director 50 未披露 未持股 2017-09-11
Randal R. Betz Director 64 未披露 未持股 2017-09-11
Larry Papasan Director, Co-Executive Chairman of the Board 75 未披露 未持股 2017-09-11
Jarrett Gorlin Chief Executive Officer and Director 40 27.20万美元 未持股 2017-09-11
C. A. Hennies Director 78 未披露 未持股 2017-09-11
Ron Lawson Director 72 未披露 未持股 2017-09-11
Jon Mogford Director 48 未披露 未持股 2017-09-11
Jesse Crowne Director, Co- Executive Chairman of the Board 33 未披露 未持股 2017-09-11
John C. Thomas, Jr. Director 62 未披露 未持股 2017-09-11

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Jarrett Gorlin Chief Executive Officer and Director 40 27.20万美元 未持股 2017-09-11
Patrick Kullmann President and Chief Operating Officer 68 23.10万美元 未持股 2017-09-11
Charles Farrahar Secretary 63 13.20万美元 未持股 2017-09-11
Dennis Moon Executive Vice President 48 20.10万美元 未持股 2017-09-11
Jeffery Wright Chief Financial Officer 41 13.00万美元 未持股 2017-09-11
Manfred Sablowski Senior Vice President of Sales & Marketing 62 15.00万美元 未持股 2017-09-11

董事简历

中英对照 |  中文 |  英文
James R. Andrews

James R. Andrews,她是公司的董事(2013年9月以来)。他的科学和临床研究的贡献被全世界公认,涉及膝盖、肩部和肘部受伤。他的技能是作为一个整形外科医生。他是the American Sports Medicine Institute(一个非盈利组织,致力于预防、教育和研究骨科运动医学)和the Andrews Research and Education Institute的创始人兼现任医疗董事。他是the University of Alabama Birmingham Medical School、the University of Virginia School of Medicine 、 the University of South Carolina Medical School的矫形外科的临床教授。他是the University of South Alabama的整形外科学系的副教授,以及 Tulane University School of Medicine的骨科临床教授。他担任Auburn University Intercollegiate Athletics and Team Orthopaedic Surgeon的医疗董事、the University of Alabama的骨科资深顾问,以及Troy University、University of West Alabama、Tuskegee University、Samford University的大学体育队的骨科顾问。他任职于杜兰大学医学院(Tulane School of Medicine)的理事会。他任职于USA Baseball的医疗和安全咨询委员会,以及Little League Baseball公司的董事会。他一直担任美国奥林匹克委员会(the United States Olympic Committee)的运动医学委员会成员,并任职于全国大学生体育协会(National Collegiate Athletic Association)的医学方面竞争保障的体育运动委员会。在职业体育领域,他是华盛顿红人足球队的高级顾问、坦帕湾光芒棒球队的医疗董事,以及女子职业高尔夫联合会的医疗董事。他担任Physiotherapy Associates公司(一个全国性的门诊康复供应商)的国家医疗董事。他任职于Fast Health Corporation,以及Robins Morton Construction Company的董事会。他拥有Livingston University的法律博士学位,以及Troy and Louisiana State Universities的理学博士学位。他最近写了一本书,《Any Given Monday》,涉及运动员、其父母和教练关心的运动员运动损伤以及如何阻止


James R. Andrews has served as a Director of the Company since September 2013. Dr. Andrews is recognized throughout the world for his scientific and clinical research contributions in knee, shoulder and elbow injuries, and his skill as an orthopedic surgeon. Dr. Andrews is a founder and current Medical Director for the American Sports Medicine Institute, a non-profit organization dedicated to the prevention, education and research in orthopaedic and sports medicine, as well as the Andrews Research and Education Institute.He is Clinical Professor of Orthopaedic Surgery at the University of Alabama Birmingham Medical School, the University of Virginia School of Medicine and the University of South Carolina Medical School. He is Adjunct Professor in the Department of Orthopaedic Surgery at the University of South Alabama and Clinical Professor of Orthopaedics at Tulane University School of Medicine.He serves as Medical Director for Auburn University Intercollegiate Athletics and Team Orthopaedic Surgeon; Senior Orthopaedic Consultant at the University of Alabama; Orthopaedic Consultant for the college athletic teams at Troy University, University of West Alabama, Tuskegee University and Samford University. He serves on the Tulane School of Medicine Board of Governors.Dr. Andrews serves on the Medical and Safety Advisory Committee of USA Baseball and on the Board of Little League Baseball, Inc. He has been a member of the Sports Medicine Committee of the United States Olympic Committee and served on the NCAA Competitive Safeguards in Medical Aspects of Sports Committee.
James R. Andrews,她是公司的董事(2013年9月以来)。他的科学和临床研究的贡献被全世界公认,涉及膝盖、肩部和肘部受伤。他的技能是作为一个整形外科医生。他是the American Sports Medicine Institute(一个非盈利组织,致力于预防、教育和研究骨科运动医学)和the Andrews Research and Education Institute的创始人兼现任医疗董事。他是the University of Alabama Birmingham Medical School、the University of Virginia School of Medicine 、 the University of South Carolina Medical School的矫形外科的临床教授。他是the University of South Alabama的整形外科学系的副教授,以及 Tulane University School of Medicine的骨科临床教授。他担任Auburn University Intercollegiate Athletics and Team Orthopaedic Surgeon的医疗董事、the University of Alabama的骨科资深顾问,以及Troy University、University of West Alabama、Tuskegee University、Samford University的大学体育队的骨科顾问。他任职于杜兰大学医学院(Tulane School of Medicine)的理事会。他任职于USA Baseball的医疗和安全咨询委员会,以及Little League Baseball公司的董事会。他一直担任美国奥林匹克委员会(the United States Olympic Committee)的运动医学委员会成员,并任职于全国大学生体育协会(National Collegiate Athletic Association)的医学方面竞争保障的体育运动委员会。在职业体育领域,他是华盛顿红人足球队的高级顾问、坦帕湾光芒棒球队的医疗董事,以及女子职业高尔夫联合会的医疗董事。他担任Physiotherapy Associates公司(一个全国性的门诊康复供应商)的国家医疗董事。他任职于Fast Health Corporation,以及Robins Morton Construction Company的董事会。他拥有Livingston University的法律博士学位,以及Troy and Louisiana State Universities的理学博士学位。他最近写了一本书,《Any Given Monday》,涉及运动员、其父母和教练关心的运动员运动损伤以及如何阻止
James R. Andrews has served as a Director of the Company since September 2013. Dr. Andrews is recognized throughout the world for his scientific and clinical research contributions in knee, shoulder and elbow injuries, and his skill as an orthopedic surgeon. Dr. Andrews is a founder and current Medical Director for the American Sports Medicine Institute, a non-profit organization dedicated to the prevention, education and research in orthopaedic and sports medicine, as well as the Andrews Research and Education Institute.He is Clinical Professor of Orthopaedic Surgery at the University of Alabama Birmingham Medical School, the University of Virginia School of Medicine and the University of South Carolina Medical School. He is Adjunct Professor in the Department of Orthopaedic Surgery at the University of South Alabama and Clinical Professor of Orthopaedics at Tulane University School of Medicine.He serves as Medical Director for Auburn University Intercollegiate Athletics and Team Orthopaedic Surgeon; Senior Orthopaedic Consultant at the University of Alabama; Orthopaedic Consultant for the college athletic teams at Troy University, University of West Alabama, Tuskegee University and Samford University. He serves on the Tulane School of Medicine Board of Governors.Dr. Andrews serves on the Medical and Safety Advisory Committee of USA Baseball and on the Board of Little League Baseball, Inc. He has been a member of the Sports Medicine Committee of the United States Olympic Committee and served on the NCAA Competitive Safeguards in Medical Aspects of Sports Committee.
Scott M. W. Haufe

Scott M. W. Haufe,他是Debride公司的共同创始人,并一直担任公司的董事(2013年9月以来)。他获得麻醉、疼痛医学和临终关怀和姑息医学的专业认证。他开始了他的麻醉学领域职业生涯,在那里他曾担任St. Lucie Anesthesia Associates的麻醉学和疼痛管理职员(直到1998年),同时继续研究。他于1993年首次出版,并已经撰写了许多同行评议的杂志文章。具体地说,他于2005年出版的荐肠关节炎内镜治疗得到认可。2006年,他再次撰写第一篇椎间盘内干细胞疗法论文,试图恢复人类的圆盘,并于2010年开发了一种微创手术,用于解决脊柱关节炎,随后他的发现被发表在《内部医疗科学杂志》上。此外,他以治疗疼痛的相关问题的多个专利而闻名。他于1992年获得the University of South Florida College of Medicine的荣誉医学博士学位,并于1996年完成麻醉学驻院实习。他目前在佛罗里达州德斯坦执业,任职Anesthesia公司,并隶属于Sacred Heart Hospital、Destin Surgery Center、Healthmark Medical Center。他是the American Society of Anesthesiologists、the Florida Society of Anesthesiologists的成员。


Scott M. W. Haufe is a co-founder of Debride and has been a Director of the Company since September 2013. Dr. Haufe is a board certified physician in the fields of Anesthesiology, Pain Medicine and Hospice /Palliative Medicine. He began his career in the field of Anesthesiology where he served as Chief of Anesthesiology and Pain Management with St. Lucie Anesthesia Associates until 1998 while continuing his passion for research. Beginning in 1993 Dr. Haufe was first published and has since authored numerous peer reviewed journal articles. Specifically, in 2005 he was recognized for his publication on the endoscopic treatment for sacroilitis. During 2006 he again authored the first paper on intradiscal stem cell therapy in an attempt to rejuvenate the human disc and in 2010 he developed a minimally invasive procedure for resolving spinal arthritis and subsequently published his findings in the Internal Journal of Med Sci. Additionally, he is named on multiple patents for treating pain related issues. Dr. Haufe earned his MD from the University of South Florida College of Medicine in 1992 with honors and completed his residency in Anesthesiology in 1996. He currently practices in Destin, FL with Anesthesia, Inc., and is affiliated with Sacred Heart Hospital, Destin Surgery Center, and Healthmark Medical Center. He is a member of the American Society of Anesthesiologists and the Florida Society of Anesthesiologists.
Scott M. W. Haufe,他是Debride公司的共同创始人,并一直担任公司的董事(2013年9月以来)。他获得麻醉、疼痛医学和临终关怀和姑息医学的专业认证。他开始了他的麻醉学领域职业生涯,在那里他曾担任St. Lucie Anesthesia Associates的麻醉学和疼痛管理职员(直到1998年),同时继续研究。他于1993年首次出版,并已经撰写了许多同行评议的杂志文章。具体地说,他于2005年出版的荐肠关节炎内镜治疗得到认可。2006年,他再次撰写第一篇椎间盘内干细胞疗法论文,试图恢复人类的圆盘,并于2010年开发了一种微创手术,用于解决脊柱关节炎,随后他的发现被发表在《内部医疗科学杂志》上。此外,他以治疗疼痛的相关问题的多个专利而闻名。他于1992年获得the University of South Florida College of Medicine的荣誉医学博士学位,并于1996年完成麻醉学驻院实习。他目前在佛罗里达州德斯坦执业,任职Anesthesia公司,并隶属于Sacred Heart Hospital、Destin Surgery Center、Healthmark Medical Center。他是the American Society of Anesthesiologists、the Florida Society of Anesthesiologists的成员。
Scott M. W. Haufe is a co-founder of Debride and has been a Director of the Company since September 2013. Dr. Haufe is a board certified physician in the fields of Anesthesiology, Pain Medicine and Hospice /Palliative Medicine. He began his career in the field of Anesthesiology where he served as Chief of Anesthesiology and Pain Management with St. Lucie Anesthesia Associates until 1998 while continuing his passion for research. Beginning in 1993 Dr. Haufe was first published and has since authored numerous peer reviewed journal articles. Specifically, in 2005 he was recognized for his publication on the endoscopic treatment for sacroilitis. During 2006 he again authored the first paper on intradiscal stem cell therapy in an attempt to rejuvenate the human disc and in 2010 he developed a minimally invasive procedure for resolving spinal arthritis and subsequently published his findings in the Internal Journal of Med Sci. Additionally, he is named on multiple patents for treating pain related issues. Dr. Haufe earned his MD from the University of South Florida College of Medicine in 1992 with honors and completed his residency in Anesthesiology in 1996. He currently practices in Destin, FL with Anesthesia, Inc., and is affiliated with Sacred Heart Hospital, Destin Surgery Center, and Healthmark Medical Center. He is a member of the American Society of Anesthesiologists and the Florida Society of Anesthesiologists.
Randal R. Betz

Randal R. Betz ,他一直担任公司的董事(2013年9月以来)。他是一个新泽西普林斯顿私人诊所的骨科脊柱外科医生。他也曾担任Shriners Hospitals for Children的办公室主任,以及Shriners公司的脊髓损伤单元的医疗董事。他也是Temple University School of Medicine的整形外科教授。他获得Temple University School of Medicine的医学学位,并获得阿拉法·俄梅戛·阿拉法医学荣誉。他在Temple University Hospital进行整形外科手术的普通外科实习和驻院实习。他曾担任the Alfred I DuPont Institute的小儿骨科学研究员。自从他毕业工作,他曾担任研究员,涉及ABC Traveling Fellowship、North American Traveling Fellowship、SRS Traveling fellowship、the Berg-Sloat Traveling Fellowship。他担任许多国家和国际专业社会的成员,包括he Academic Orthopedic Society、American Academy for Cerebral Palsy and Developmental Medicine、American Academy of Orthopedic Surgeons、American Orthopedic Association、American Paraplegia Society、American Spinal Injury Association、British Scoliosis Society、International Functional Electrical Stimulation Society、North American Spine Society、Pediatric Orthopedic Society of North America、Scoliosis Research Society、Spinal Deformity Education Group。就许多组织而言,他于2005年已经担任the Scoliosis Research Society的董事会成员、委员会成员,以及主席。除了活跃的小儿脊柱外科医院实践,研究对他的职业生涯而言也是重要的。他获得了许多研究资助,并拥有十项专利,包括一些涉及研究脊柱畸形:脊柱畸形的少融合治疗。他是一些医学文献的作者。他曾贡献45章医学书籍,并撰写280篇同行评议或邀请的文章。在世界范围内,他发表了数以百计的论文报告,并受邀讲座。他任职于《小儿骨科杂志》(the Journal of Pediatric Orthopedics)的编辑部,担任《骨和关节手术》(the Journal of Bone and Joint Surgery)、《小儿矫形杂志》(Journal of Pediatric Orthopedics)、《Spine》的审稿人。


Randal R. Betz has been a director of the Company since September 2013. Dr. Betz is an orthopedic spine surgeon with a private practice in Princeton, New Jersey. Dr. Betz has held hospital positions as Chief of Staff at Shriners Hospitals for Children and Medical Director of Shriners’ Spinal Cord Injury Unit. Dr. Betz is also a Professor of Orthopedic Surgery at Temple University School of Medicine.Dr. Betz earned a Medical Degree from Temple University School of Medicine and was awarded the Alpha Omega Alpha honor. His Internship in general surgery and Residency in Orthopedic Surgery were at Temple University Hospital. Dr. Betz’s Fellowship in Pediatric Orthopedics was at the Alfred I DuPont Institute. Since his graduate work, Dr. Betz has had postdoctoral fellowship experiences with ABC Traveling Fellowship, North American Traveling Fellowship, SRS Traveling fellowship and the Berg-Sloat Traveling Fellowship. Many national and international professional societies count Dr. Betz as a member including: the Academic Orthopedic Society, American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Orthopedic Surgeons, American Orthopedic Association, American Paraplegia Society, American Spinal Injury Association, British Scoliosis Society, International Functional Electrical Stimulation Society, North American Spine Society, Pediatric Orthopedic Society of North America, Scoliosis Research Society, and Spinal Deformity Education Group. For many of these organizations, Dr. Betz has fulfilled the roles of board of director member, committee member and President of the Scoliosis Research Society in 2005.
Randal R. Betz ,他一直担任公司的董事(2013年9月以来)。他是一个新泽西普林斯顿私人诊所的骨科脊柱外科医生。他也曾担任Shriners Hospitals for Children的办公室主任,以及Shriners公司的脊髓损伤单元的医疗董事。他也是Temple University School of Medicine的整形外科教授。他获得Temple University School of Medicine的医学学位,并获得阿拉法·俄梅戛·阿拉法医学荣誉。他在Temple University Hospital进行整形外科手术的普通外科实习和驻院实习。他曾担任the Alfred I DuPont Institute的小儿骨科学研究员。自从他毕业工作,他曾担任研究员,涉及ABC Traveling Fellowship、North American Traveling Fellowship、SRS Traveling fellowship、the Berg-Sloat Traveling Fellowship。他担任许多国家和国际专业社会的成员,包括he Academic Orthopedic Society、American Academy for Cerebral Palsy and Developmental Medicine、American Academy of Orthopedic Surgeons、American Orthopedic Association、American Paraplegia Society、American Spinal Injury Association、British Scoliosis Society、International Functional Electrical Stimulation Society、North American Spine Society、Pediatric Orthopedic Society of North America、Scoliosis Research Society、Spinal Deformity Education Group。就许多组织而言,他于2005年已经担任the Scoliosis Research Society的董事会成员、委员会成员,以及主席。除了活跃的小儿脊柱外科医院实践,研究对他的职业生涯而言也是重要的。他获得了许多研究资助,并拥有十项专利,包括一些涉及研究脊柱畸形:脊柱畸形的少融合治疗。他是一些医学文献的作者。他曾贡献45章医学书籍,并撰写280篇同行评议或邀请的文章。在世界范围内,他发表了数以百计的论文报告,并受邀讲座。他任职于《小儿骨科杂志》(the Journal of Pediatric Orthopedics)的编辑部,担任《骨和关节手术》(the Journal of Bone and Joint Surgery)、《小儿矫形杂志》(Journal of Pediatric Orthopedics)、《Spine》的审稿人。
Randal R. Betz has been a director of the Company since September 2013. Dr. Betz is an orthopedic spine surgeon with a private practice in Princeton, New Jersey. Dr. Betz has held hospital positions as Chief of Staff at Shriners Hospitals for Children and Medical Director of Shriners’ Spinal Cord Injury Unit. Dr. Betz is also a Professor of Orthopedic Surgery at Temple University School of Medicine.Dr. Betz earned a Medical Degree from Temple University School of Medicine and was awarded the Alpha Omega Alpha honor. His Internship in general surgery and Residency in Orthopedic Surgery were at Temple University Hospital. Dr. Betz’s Fellowship in Pediatric Orthopedics was at the Alfred I DuPont Institute. Since his graduate work, Dr. Betz has had postdoctoral fellowship experiences with ABC Traveling Fellowship, North American Traveling Fellowship, SRS Traveling fellowship and the Berg-Sloat Traveling Fellowship. Many national and international professional societies count Dr. Betz as a member including: the Academic Orthopedic Society, American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Orthopedic Surgeons, American Orthopedic Association, American Paraplegia Society, American Spinal Injury Association, British Scoliosis Society, International Functional Electrical Stimulation Society, North American Spine Society, Pediatric Orthopedic Society of North America, Scoliosis Research Society, and Spinal Deformity Education Group. For many of these organizations, Dr. Betz has fulfilled the roles of board of director member, committee member and President of the Scoliosis Research Society in 2005.
Larry Papasan

Larry Papasan,他一直担任公司的董事会成员(2013年9月以来)。从1991年7月到2002年5月退休,他曾担任Smith & Nephew Orthopedics公司的总裁。他一直担任BioMimetic Therapeutics, Inc. 【NasdaqGM:BMTI】 的董事兼董事会主席(2005年8月以来)。BioMimetic Therapeutics公司是产品开发和商业化生物活性重组蛋白质活性组合的治疗肌肉骨骼伤害和疾病(包括骨科、牙周、脊椎和运动损伤的应用)的产品。他也曾担任Reaves Utility Income Fund 【NasdaqCM:UTG】(封闭式管理投资公司)(2003年2月以来),以及 Triumph Bancshares公司(银行控股公司)(2005年4月以来)的董事会成员。他也曾担任SSR Engineering公司、AxioMed Spine Corporation、MiMedx Group公司的董事。


Larry Papasan has served as Chairman of the board of directors of the Company since September 2013. From July 1991 until his retirement in May 2002 Mr. Papasan served as President of Smith & Nephew Orthopedics. He has been a Director and Chairman of the board of directors of BioMimetic Therapeutics, Inc. [NasdaqGM:BMTI] since August 2005. BioMimetic Therapeutics is developing and commercializing bio-active recombinant protein-device combination products for the healing of musculoskeletal injuries and disease, including orthopedic, periodontal, spine and sports injury applications. Mr. Papasan has also served as a member of the board of directors of Reaves Utility Income Fund [NasdaqCM:UTG], a closed-end management investment company, since February 2003 and of Triumph Bancshares, Inc. a bank holding company since April 2005. Mr. Papasan also serves as a Director of SSR Engineering, Inc., AxioMed Spine Corporation, and MiMedx Group, Inc.
Larry Papasan,他一直担任公司的董事会成员(2013年9月以来)。从1991年7月到2002年5月退休,他曾担任Smith & Nephew Orthopedics公司的总裁。他一直担任BioMimetic Therapeutics, Inc. 【NasdaqGM:BMTI】 的董事兼董事会主席(2005年8月以来)。BioMimetic Therapeutics公司是产品开发和商业化生物活性重组蛋白质活性组合的治疗肌肉骨骼伤害和疾病(包括骨科、牙周、脊椎和运动损伤的应用)的产品。他也曾担任Reaves Utility Income Fund 【NasdaqCM:UTG】(封闭式管理投资公司)(2003年2月以来),以及 Triumph Bancshares公司(银行控股公司)(2005年4月以来)的董事会成员。他也曾担任SSR Engineering公司、AxioMed Spine Corporation、MiMedx Group公司的董事。
Larry Papasan has served as Chairman of the board of directors of the Company since September 2013. From July 1991 until his retirement in May 2002 Mr. Papasan served as President of Smith & Nephew Orthopedics. He has been a Director and Chairman of the board of directors of BioMimetic Therapeutics, Inc. [NasdaqGM:BMTI] since August 2005. BioMimetic Therapeutics is developing and commercializing bio-active recombinant protein-device combination products for the healing of musculoskeletal injuries and disease, including orthopedic, periodontal, spine and sports injury applications. Mr. Papasan has also served as a member of the board of directors of Reaves Utility Income Fund [NasdaqCM:UTG], a closed-end management investment company, since February 2003 and of Triumph Bancshares, Inc. a bank holding company since April 2005. Mr. Papasan also serves as a Director of SSR Engineering, Inc., AxioMed Spine Corporation, and MiMedx Group, Inc.
Jarrett Gorlin

Jarrett Gorlin,他曾担任公司的首席执行官、总裁,以及董事(2013年11月以来)。加入公司之前,他曾担任Judicial Correction Services公司(JCS,全国最大的私人缓刑服务供应商,他于2001年合伙创建的公司)的总裁。他于2011年成功地达成JCS公司出售给Correctional Healthcare Companies (“CHC”),此后继续担任JCS公司的总裁。在他的领导下,JCS公司促成了INC。2010年、2011年和2012年的美国增长最快的公司的杂志名单。他的职业生涯始于16岁时成为最年轻的额定商业直升机飞行员,以及格鲁吉亚亚特兰大富尔顿县警长办公室的首席飞行员。他曾担任富尔顿县警长办公室的船长和指挥官(从1996年到现在)。他继续通过执法服务社区,作为储备单位的指挥官,负责监督法庭、监狱和保证部门的90名副行政长官。他也担任亚特兰大地区许多民选官员(包括富尔顿和格鲁吉亚克莱顿县的治安官)的政治顾问和顾问。他也曾任职于乔治亚州的前州长罗伊·巴恩斯的竞选财务委员会。


Jarrett Gorlin has served as the Chief Executive Officer, President, and a Director of the Company since November, 2013. Prior to joining the Company, Mr. Gorlin served as the President of Judicial Correction Services, Inc. “JCS”, the largest provider of private probation services in the country, which he co-founded in 2001. In 2011 he successfully negotiated the sale of JCS to Correctional Healthcare Companies (“CHC”), after which he has continued to serve as the President of JCS. Under Mr. Gorlin’s leadership, JCS made INC. Magazine’s list of the Fastest Growing Companies in America in 2010 2011 and 2012. Mr. Gorlin began his career by becoming the youngest rated commercial helicopter pilot at the age of 16 and becoming the chief pilot for the Fulton County Sheriff’s Office in Atlanta, Georgia. Mr. Gorlin has served a Captain and Commander at the Fulton County Sheriff’s Office where he has worked from 1996 to present. He continues to serve his community through law enforcement as the commander of a reserve unit overseeing 90 deputy sheriffs, who work in the courts, jail and warrant divisions. Mr. Gorlin also serves as a political advisor and consultant to many elected officials in the Atlanta area, including the current sitting Sheriff of Fulton and Clayton County, Georgia. He has also served on the campaign finance committeefor the former Governor of Georgia Roy Barnes.
Jarrett Gorlin,他曾担任公司的首席执行官、总裁,以及董事(2013年11月以来)。加入公司之前,他曾担任Judicial Correction Services公司(JCS,全国最大的私人缓刑服务供应商,他于2001年合伙创建的公司)的总裁。他于2011年成功地达成JCS公司出售给Correctional Healthcare Companies (“CHC”),此后继续担任JCS公司的总裁。在他的领导下,JCS公司促成了INC。2010年、2011年和2012年的美国增长最快的公司的杂志名单。他的职业生涯始于16岁时成为最年轻的额定商业直升机飞行员,以及格鲁吉亚亚特兰大富尔顿县警长办公室的首席飞行员。他曾担任富尔顿县警长办公室的船长和指挥官(从1996年到现在)。他继续通过执法服务社区,作为储备单位的指挥官,负责监督法庭、监狱和保证部门的90名副行政长官。他也担任亚特兰大地区许多民选官员(包括富尔顿和格鲁吉亚克莱顿县的治安官)的政治顾问和顾问。他也曾任职于乔治亚州的前州长罗伊·巴恩斯的竞选财务委员会。
Jarrett Gorlin has served as the Chief Executive Officer, President, and a Director of the Company since November, 2013. Prior to joining the Company, Mr. Gorlin served as the President of Judicial Correction Services, Inc. “JCS”, the largest provider of private probation services in the country, which he co-founded in 2001. In 2011 he successfully negotiated the sale of JCS to Correctional Healthcare Companies (“CHC”), after which he has continued to serve as the President of JCS. Under Mr. Gorlin’s leadership, JCS made INC. Magazine’s list of the Fastest Growing Companies in America in 2010 2011 and 2012. Mr. Gorlin began his career by becoming the youngest rated commercial helicopter pilot at the age of 16 and becoming the chief pilot for the Fulton County Sheriff’s Office in Atlanta, Georgia. Mr. Gorlin has served a Captain and Commander at the Fulton County Sheriff’s Office where he has worked from 1996 to present. He continues to serve his community through law enforcement as the commander of a reserve unit overseeing 90 deputy sheriffs, who work in the courts, jail and warrant divisions. Mr. Gorlin also serves as a political advisor and consultant to many elected officials in the Atlanta area, including the current sitting Sheriff of Fulton and Clayton County, Georgia. He has also served on the campaign finance committeefor the former Governor of Georgia Roy Barnes.
C. A. Hennies

C. A. Hennies于2013年9月成为公司董事。Lou Hennies是一名职业军人,穿着制服为国家贡献了41年多,等级从招募状态到军官,2001年退休时已担任上将。他在越南战役中服役了37个月,担任4个作战单位的公司/部队指挥官以及4th Battalion, 23rd Infantry Regiment, 25th Infantry Division, Cu Chi, and the 7th Squadron, 17th Air Cavalry in II Corps4th Battalion, 23rd Infantry Regiment, 25th Infantry Division, Cu Chi, and the 7th Squadron, 17th Air Cavalry in II Corps中队/营指挥官。在美国国内,他指挥另一Air Cavalry Troop军队,随后担任82nd Airborne Division的1st Squadron, 17th Air Cavalry指挥官。1986年被选为准将,之后不久担任军队公共事务副主任以及军队战略主管以及the U.S Army Safety Center指挥官。1991年退休,1995年回到军队担任Alabama Army and Air National Guard的上将副将;Administration of Governor Fob James Jr.议会官。他是Army's Command and General Staff College, The Army War College, 以及 The Center for Creative Leadership毕业生。身为the University of Nebraska-Omaha毕业生,他持有政治科学学士学位,还持有the University of Nebraska-Lincoln新闻学硕士学位;宾夕法尼亚州Shippensburg University政治管理理学硕士学位。他的奖项和荣誉包括Army Distinguished Medal with Oak Leaf Cluster, the Silver Star, the Legion of Merit with Oak Leaf Cluster, the Distinguished Flying Cross, the Soldiers Medal, the Bronze Star with V'device and 5 Oak Leaf Clusters, the Purple Heart, the Air Medal with “V” -2 and numeral 29 and the Alabama Distinguished Medal with Oak Leaf Cluster。他也是越南共和国和朝鲜共和国多个外国荣誉的获得者。他曾被授予the Army Aviation Order of Saint Michael (Gold), the Infantry's Order of Saint Maurice (Primercius) and the Army Aviation Hall of Fame Medallion;被引荐进入Infantry Officer Candidate Hall of Fame, the Army Aviation Hall of Fame, and the Air Force Gathering of Eagles Class of 2000。


C. A. Hennies became a director of the Company in September 2013. Lou Hennies is a career soldier having served his country in uniform for 41 years where he rose through the ranks from enlisted status to that of a commissioned officer retiring in 2001 as a Major General.He served a total of 37 months in combat in Republic of Vietnam as a Company/Troop commander of four units and as a battalion/squadron staff officer in the 4th Battalion, 23rd Infantry Regiment, 25th Infantry Division, Cu Chi, and the 7th Squadron, 17th Air Cavalry in II Corps. Stateside he commanded another Air Cavalry Troop followed by command of the 1st Squadron, 17th Air Cavalry in the 82nd Airborne Division.Selected for Brigadier General in 1986 he subsequently served as the Army's Deputy Chief of Public Affairs and Director of Army Safety and Commanding General of the U.S Army Safety Center. Initially retiring in 1991 he returned to service in 1995 as The Adjutant General TAG of the Alabama Army and Air National Guard and as a Cabinet Officer in the Administration of Governor Fob James Jr.He is a graduate of the Army's Command and General Staff College, The Army War College, and The Center for Creative Leadership. A graduate of the University of Nebraska-Omaha with a Bachelor Degree in Political Science, he also holds a Master of Arts Degree in Journalism from the University of Nebraska-Lincoln and a Master of Science in Public Administration from Shippensburg University, Pennsylvania.
C. A. Hennies于2013年9月成为公司董事。Lou Hennies是一名职业军人,穿着制服为国家贡献了41年多,等级从招募状态到军官,2001年退休时已担任上将。他在越南战役中服役了37个月,担任4个作战单位的公司/部队指挥官以及4th Battalion, 23rd Infantry Regiment, 25th Infantry Division, Cu Chi, and the 7th Squadron, 17th Air Cavalry in II Corps4th Battalion, 23rd Infantry Regiment, 25th Infantry Division, Cu Chi, and the 7th Squadron, 17th Air Cavalry in II Corps中队/营指挥官。在美国国内,他指挥另一Air Cavalry Troop军队,随后担任82nd Airborne Division的1st Squadron, 17th Air Cavalry指挥官。1986年被选为准将,之后不久担任军队公共事务副主任以及军队战略主管以及the U.S Army Safety Center指挥官。1991年退休,1995年回到军队担任Alabama Army and Air National Guard的上将副将;Administration of Governor Fob James Jr.议会官。他是Army's Command and General Staff College, The Army War College, 以及 The Center for Creative Leadership毕业生。身为the University of Nebraska-Omaha毕业生,他持有政治科学学士学位,还持有the University of Nebraska-Lincoln新闻学硕士学位;宾夕法尼亚州Shippensburg University政治管理理学硕士学位。他的奖项和荣誉包括Army Distinguished Medal with Oak Leaf Cluster, the Silver Star, the Legion of Merit with Oak Leaf Cluster, the Distinguished Flying Cross, the Soldiers Medal, the Bronze Star with V'device and 5 Oak Leaf Clusters, the Purple Heart, the Air Medal with “V” -2 and numeral 29 and the Alabama Distinguished Medal with Oak Leaf Cluster。他也是越南共和国和朝鲜共和国多个外国荣誉的获得者。他曾被授予the Army Aviation Order of Saint Michael (Gold), the Infantry's Order of Saint Maurice (Primercius) and the Army Aviation Hall of Fame Medallion;被引荐进入Infantry Officer Candidate Hall of Fame, the Army Aviation Hall of Fame, and the Air Force Gathering of Eagles Class of 2000。
C. A. Hennies became a director of the Company in September 2013. Lou Hennies is a career soldier having served his country in uniform for 41 years where he rose through the ranks from enlisted status to that of a commissioned officer retiring in 2001 as a Major General.He served a total of 37 months in combat in Republic of Vietnam as a Company/Troop commander of four units and as a battalion/squadron staff officer in the 4th Battalion, 23rd Infantry Regiment, 25th Infantry Division, Cu Chi, and the 7th Squadron, 17th Air Cavalry in II Corps. Stateside he commanded another Air Cavalry Troop followed by command of the 1st Squadron, 17th Air Cavalry in the 82nd Airborne Division.Selected for Brigadier General in 1986 he subsequently served as the Army's Deputy Chief of Public Affairs and Director of Army Safety and Commanding General of the U.S Army Safety Center. Initially retiring in 1991 he returned to service in 1995 as The Adjutant General TAG of the Alabama Army and Air National Guard and as a Cabinet Officer in the Administration of Governor Fob James Jr.He is a graduate of the Army's Command and General Staff College, The Army War College, and The Center for Creative Leadership. A graduate of the University of Nebraska-Omaha with a Bachelor Degree in Political Science, he also holds a Master of Arts Degree in Journalism from the University of Nebraska-Lincoln and a Master of Science in Public Administration from Shippensburg University, Pennsylvania.
Ron Lawson

Ron Lawson,于2016年8月成为公司的董事,基于Thomas Hills自愿辞职。他在整形行业有着超过35年的经验。他于1996年担任Pfizer公司的整形部门(Howmedica)的高级副总裁,负责全球销售和客户服务。他于1998年Stryker Corporation收购Howmedica时被任命为高级副总裁,负责销售、营销和产品开发。他于2000年受邀领导振兴Stryker公司的欧洲业务,作为其欧洲、中东和非洲总裁,并于2001年被提拔为国际集团总裁。2005年至2007年,他曾担任Stryker公司的集体照总裁,负责国际和全球整形外科,在那里他专注于加强Stryker整形全球业务。2009年以来,他一直担任 the Lawson Group的成员,在那里他曾提供战略咨询服务,专注于骨科医疗技术。他此前曾担任IMDS, Corporation的董事会主席,也曾担任Arsenal Capital Partners公司的医疗咨询委员会的成员。他目前担任Plasmology 4 Corporation的董事,以及DJO Global(Blackstone公司)的董事。


Ron Lawson became a director of the Company in August 2016 following the voluntary resignation of Thomas Hills. Mr. Lawson has over 35 years of experience in the orthopedic industry. In 1996 he served as the Senior Vice President of Worldwide Sales and Customer Service for Pfizer’s Orthopedic Division, Howmedica. In 1998 upon Stryker Corporation’s acquisition of Howmedica, Mr. Lawson was appointed to serve as Senior Vice President of Sales, Marketing and Product Development. In 2000 he was asked to lead the revitalization of Stryker’s European business as its President, EMEA and in 2001 was promoted to Group President, International. From 2005 to 2007 Mr. Lawson served as Stryker’s Group President for International and Global Orthopedics where he was focused on strengthening the Stryker Orthopedic business worldwide. Since 2009 Mr. Lawson has been a member of the Lawson Group where he provides strategic consulting services specializing in orthopedic medical technology.
Ron Lawson,于2016年8月成为公司的董事,基于Thomas Hills自愿辞职。他在整形行业有着超过35年的经验。他于1996年担任Pfizer公司的整形部门(Howmedica)的高级副总裁,负责全球销售和客户服务。他于1998年Stryker Corporation收购Howmedica时被任命为高级副总裁,负责销售、营销和产品开发。他于2000年受邀领导振兴Stryker公司的欧洲业务,作为其欧洲、中东和非洲总裁,并于2001年被提拔为国际集团总裁。2005年至2007年,他曾担任Stryker公司的集体照总裁,负责国际和全球整形外科,在那里他专注于加强Stryker整形全球业务。2009年以来,他一直担任 the Lawson Group的成员,在那里他曾提供战略咨询服务,专注于骨科医疗技术。他此前曾担任IMDS, Corporation的董事会主席,也曾担任Arsenal Capital Partners公司的医疗咨询委员会的成员。他目前担任Plasmology 4 Corporation的董事,以及DJO Global(Blackstone公司)的董事。
Ron Lawson became a director of the Company in August 2016 following the voluntary resignation of Thomas Hills. Mr. Lawson has over 35 years of experience in the orthopedic industry. In 1996 he served as the Senior Vice President of Worldwide Sales and Customer Service for Pfizer’s Orthopedic Division, Howmedica. In 1998 upon Stryker Corporation’s acquisition of Howmedica, Mr. Lawson was appointed to serve as Senior Vice President of Sales, Marketing and Product Development. In 2000 he was asked to lead the revitalization of Stryker’s European business as its President, EMEA and in 2001 was promoted to Group President, International. From 2005 to 2007 Mr. Lawson served as Stryker’s Group President for International and Global Orthopedics where he was focused on strengthening the Stryker Orthopedic business worldwide. Since 2009 Mr. Lawson has been a member of the Lawson Group where he provides strategic consulting services specializing in orthopedic medical technology.
Jon Mogford

Jon Mogford,担任The Texas A&M University System的研究副校长,并为系统的11个大学、七个国家机构(包括30000名教职员工)、超过135000名的学生、超过40亿美元的预算、每年超过9.45亿美元的研究支出提供研发领导。作为农工系统研究办公室(the A&M System Office of Research)的领导人,他与外部机构、基金会、学术机构和商业企业发展战略伙伴关系,从而促进系统的德克萨斯州研究、教学、服务、经济发展的任务。2011年加入the Texas A&M University System之前,他曾担任项目经理,随后担任美国国防部的the Defense Advanced Research Projects Agency (DARPA)的国防科学办公室的副主管。作为国防科学办公室的副主管,他提供物理、生物和材料科学的400美元/年研发的战略规划和实施。他为20个项目经理开发和管理办公室的投资提供领导,涉及国防和非国防应用程序的基本科学到商业化转型。他曾领导DARPA、the FDA的正式的工作关系的扩张,从而提高每个组织实现任务目标的能力,并强调白宫DARPA-FDA-NIH伙伴关系。他因杰出的公共服务获得了国防部长奖章。他的DARPA项目包括伤口的无疤痕再生、严重失血的生存代谢控制策略、药物输送的生物标志物的反应生物、万能供血者红细胞的干细胞生物反应器生产、新型蛋白质的运算设计、生物材料内部和外部的伤口的积极止血治疗。他撰写或参与撰写了29项同行评议的出版物。他获得Texas A&M University的动物学学士学位、the Texas A&M University Health Science Center(位于德克萨斯大学城)的医学生理学博士学位。他继续在the University of Chicago进行血管生理学研究,作为博士后(1997年至1998年)。他的研究重点在Northwestern University转变为伤口愈合领域,并作为一名研究助理,也担任研究助理教(1998年至2003年)。他随后担任DARPA的生命科学顾问,涉及革命性修复程序(2003年至2005年)。


Jon Mogford was appointed to our Board on February 8 2017. Dr. Mogford has served in various capacities for the Texas A&M University System "Texas A&M". Since May 2013 Dr. Mogford has served as the Vice Chancellor for Research, from August 2012 until April 2013 he served as the Chief Research Officer and from November 2011 until August 2012 he served as Associate Vice Chancellor for Strategic Initiatives at Texas A&M. Prior to joining Texas A&M in 2011 from February 2010 until October 2011 Dr. Mogford served as Deputy Director of the Defense Sciences Office (DSO) of the Defense Advanced Research Projects Agency (DARPA) in the U.S. Department of Defense. From July 2005 until January 2009 Dr. Mogford served as Program Manager of DSO of DARPA. In addition, since November 2016 Dr. Mogford has served as a member of the board of directors of Medovex Corp. Dr. Mogford is the recipient of the Secretary of Defense Medal for Outstanding Public Service. Dr. Mogford obtained his bachelor's degree in Zoology from Texas A&M University and doctorate in Medical Physiology from the Texas A&M University Health Science Center, College Station, Texas. His research in vascular physiology continued at the University of Chicago as a Postdoctoral fellow from 1997 until 1998. Dr. Mogford transitioned his research focus to the field of wound healing at Northwestern University, both as a Research Associate and as a Research Assistant Professor from 1998 until 2003. He then served as a Life Sciences Consultant to DARPA on the Revolutionizing Prosthetics program from December 2003 until June 2005.
Jon Mogford,担任The Texas A&M University System的研究副校长,并为系统的11个大学、七个国家机构(包括30000名教职员工)、超过135000名的学生、超过40亿美元的预算、每年超过9.45亿美元的研究支出提供研发领导。作为农工系统研究办公室(the A&M System Office of Research)的领导人,他与外部机构、基金会、学术机构和商业企业发展战略伙伴关系,从而促进系统的德克萨斯州研究、教学、服务、经济发展的任务。2011年加入the Texas A&M University System之前,他曾担任项目经理,随后担任美国国防部的the Defense Advanced Research Projects Agency (DARPA)的国防科学办公室的副主管。作为国防科学办公室的副主管,他提供物理、生物和材料科学的400美元/年研发的战略规划和实施。他为20个项目经理开发和管理办公室的投资提供领导,涉及国防和非国防应用程序的基本科学到商业化转型。他曾领导DARPA、the FDA的正式的工作关系的扩张,从而提高每个组织实现任务目标的能力,并强调白宫DARPA-FDA-NIH伙伴关系。他因杰出的公共服务获得了国防部长奖章。他的DARPA项目包括伤口的无疤痕再生、严重失血的生存代谢控制策略、药物输送的生物标志物的反应生物、万能供血者红细胞的干细胞生物反应器生产、新型蛋白质的运算设计、生物材料内部和外部的伤口的积极止血治疗。他撰写或参与撰写了29项同行评议的出版物。他获得Texas A&M University的动物学学士学位、the Texas A&M University Health Science Center(位于德克萨斯大学城)的医学生理学博士学位。他继续在the University of Chicago进行血管生理学研究,作为博士后(1997年至1998年)。他的研究重点在Northwestern University转变为伤口愈合领域,并作为一名研究助理,也担任研究助理教(1998年至2003年)。他随后担任DARPA的生命科学顾问,涉及革命性修复程序(2003年至2005年)。
Jon Mogford was appointed to our Board on February 8 2017. Dr. Mogford has served in various capacities for the Texas A&M University System "Texas A&M". Since May 2013 Dr. Mogford has served as the Vice Chancellor for Research, from August 2012 until April 2013 he served as the Chief Research Officer and from November 2011 until August 2012 he served as Associate Vice Chancellor for Strategic Initiatives at Texas A&M. Prior to joining Texas A&M in 2011 from February 2010 until October 2011 Dr. Mogford served as Deputy Director of the Defense Sciences Office (DSO) of the Defense Advanced Research Projects Agency (DARPA) in the U.S. Department of Defense. From July 2005 until January 2009 Dr. Mogford served as Program Manager of DSO of DARPA. In addition, since November 2016 Dr. Mogford has served as a member of the board of directors of Medovex Corp. Dr. Mogford is the recipient of the Secretary of Defense Medal for Outstanding Public Service. Dr. Mogford obtained his bachelor's degree in Zoology from Texas A&M University and doctorate in Medical Physiology from the Texas A&M University Health Science Center, College Station, Texas. His research in vascular physiology continued at the University of Chicago as a Postdoctoral fellow from 1997 until 1998. Dr. Mogford transitioned his research focus to the field of wound healing at Northwestern University, both as a Research Associate and as a Research Assistant Professor from 1998 until 2003. He then served as a Life Sciences Consultant to DARPA on the Revolutionizing Prosthetics program from December 2003 until June 2005.
Jesse Crowne

Jesse Crowne自2015年1月起担任公司业务发展Vice President。Crowne先生自2015年7月以来一直担任Gorlin Companies的管理合伙人,该公司是一家专注于梦百合的单一家族办公室,专门从事创办和资助早期企业。2015年8月至2017年1月,Crowne先生一直担任Vavotar Life Sciences的总裁,Vavotar Life Sciences是一家开发抗体导向肿瘤产品的私人临床阶段生物技术公司。自2016年以来,Crowne先生一直担任威斯敏斯特学院(Westminster College)的兼职教授,教授MBA学生融资新项目的课程。从2013年10月到2014年3月,他曾担任Virtual Clinical Trials公司(基于云的临床试验文档管理解决方案)的联席创始人,直到2014年出售给Global Deal Market公司。从2010年到2014年6月,他曾担任White Pine Medical公司(Essex Woodlands公司(私人股本投资基金,寻求后期医疗设备机会)的合伙人。


Jesse Crowne has been acting as a Vice President of Business Development for the Company since January 2015. Mr. Crowne has been a Managing Partner at Gorlin Companies, a healthcare focused single family office specializing in founding and funding early ventures since July 2015. Between August 2015 and January 2017 Mr, Crowne has been the President of Vavotar Life Sciences, a private clinical stage biotechnology company developing antibody directed oncology products. Since 2016 Mr. Crowne has served as an Adjunct Professor at Westminster College teaching a course of financing new ventures to MBA students. From October 2013 to March 2014 he was the Co-Founder of Virtual Clinic Trials, LLC, a cloud based document management solution for clinical trials until it was sold to Global Deal Market in 2014. From 2010 to June 2014 he was an associate at White Pine Medical, a subsidiary of Essex Woodlands, which was a private equity investment fund seeking late-stage medical device opportunities.
Jesse Crowne自2015年1月起担任公司业务发展Vice President。Crowne先生自2015年7月以来一直担任Gorlin Companies的管理合伙人,该公司是一家专注于梦百合的单一家族办公室,专门从事创办和资助早期企业。2015年8月至2017年1月,Crowne先生一直担任Vavotar Life Sciences的总裁,Vavotar Life Sciences是一家开发抗体导向肿瘤产品的私人临床阶段生物技术公司。自2016年以来,Crowne先生一直担任威斯敏斯特学院(Westminster College)的兼职教授,教授MBA学生融资新项目的课程。从2013年10月到2014年3月,他曾担任Virtual Clinical Trials公司(基于云的临床试验文档管理解决方案)的联席创始人,直到2014年出售给Global Deal Market公司。从2010年到2014年6月,他曾担任White Pine Medical公司(Essex Woodlands公司(私人股本投资基金,寻求后期医疗设备机会)的合伙人。
Jesse Crowne has been acting as a Vice President of Business Development for the Company since January 2015. Mr. Crowne has been a Managing Partner at Gorlin Companies, a healthcare focused single family office specializing in founding and funding early ventures since July 2015. Between August 2015 and January 2017 Mr, Crowne has been the President of Vavotar Life Sciences, a private clinical stage biotechnology company developing antibody directed oncology products. Since 2016 Mr. Crowne has served as an Adjunct Professor at Westminster College teaching a course of financing new ventures to MBA students. From October 2013 to March 2014 he was the Co-Founder of Virtual Clinic Trials, LLC, a cloud based document management solution for clinical trials until it was sold to Global Deal Market in 2014. From 2010 to June 2014 he was an associate at White Pine Medical, a subsidiary of Essex Woodlands, which was a private equity investment fund seeking late-stage medical device opportunities.
John C. Thomas, Jr.

John C. Thomas, Jr.从2012年开始担任QLT的董事,并担任QLT的审计与风险、公司治理与提名和薪酬委员会的委员。Thomas先生拥有超过38年的多个财务与会计职位的工作经验,最后28年在医疗、制药与设备领域度过。Thomas先生目前还担任CorMatrix的首席财务官、秘书与董事(从2001年开始任职),这是一家私人所有的的医疗设备公司,并担任Motion Reality, Inc.的首席财务官、秘书与董事(从1991年开始任职),这是一家动作捕捉与模拟公司。过去10年间,Thomas先生担任DemeRx, Inc.的代理首席财务官(从2010年到2011年);担任MRI干预公司(MRI Interventions, Inc.)的首席财务官(从1998年到2010年),担任MiMedx Group, Inc. 的首席财务官(从2007年到2008年),并担任DARA BioSciences的首席财务官(从2003年到2009年);并担任MRI干预公司的董事(从2004年到2011年),于2012年担任DARA BioSciences的董事。在这之前,Thomas先生还担任沃克中学(Walker School)的理事,随后担任财务委员会主席, 这是一家私人的从学前班到12学级的小学(从1999年到2012年)。Thomas先生是一位注册会计师,并毕业于弗吉尼亚大学(University of Virginia)麦金太尔商学院(McIntire School of Commerce),于1975年以优异的成绩获得商业理学学士学位。


John C. Thomas, Jr. will be a director upon the completion of the Corporate Conversion. Since 2018 Mr. Thomas has served as the Chief Financial Officer and Secretary of SmartPharm Therapeutics, Inc, a genetic research and development company. In late 2017 Mr. Thomas rejoined DemeRx, Inc., a privately held company developing non-additive treatments for drug addiction, as the Chief Financial Officer after previously being the Chief Financial Officer from 2010 to 2013. Since April 2014 Mr. Thomas has served as a director of NantKwest, Inc. Nasdaq: NK and is chairperson of the audit committee and a member of the compensation committee. From 2001 until 2018 Mr. Thomas served as Chief Financial Officer and Secretary, and from 2001 to 2016 as a director of CorMatrix Cardiovascular, a privately held medical device company. He has also served as Chief Financial Officer, Secretary, and Director of Motion Reality, Inc., a motion capture and simulation company, since 1991. From 2012 until 2019 Mr. Thomas served as a director of Novelion Therapeutics, Inc. (formerly QLT, Inc.), a public company focused on rare diseases and was the Chairperson of their Audit and Risk Committee and Nominating and Governance Committee. During the past ten years, Mr. Thomas served as acting Chief Financial Officer for DemeRx, Inc., MRI Interventions, Inc., MiMedx Group, Inc., and DARA BioSciences and as a director of MRI Interventions, Inc. Between 1999 and 2012 Mr. Thomas served as a Trustee and subsequently the Chairman of the Finance Committee of The Walker School, a private school. Mr. Thomas is a Certified Public Accountant and graduated from the University of Virginia, McIntire School of Commerce.
John C. Thomas, Jr.从2012年开始担任QLT的董事,并担任QLT的审计与风险、公司治理与提名和薪酬委员会的委员。Thomas先生拥有超过38年的多个财务与会计职位的工作经验,最后28年在医疗、制药与设备领域度过。Thomas先生目前还担任CorMatrix的首席财务官、秘书与董事(从2001年开始任职),这是一家私人所有的的医疗设备公司,并担任Motion Reality, Inc.的首席财务官、秘书与董事(从1991年开始任职),这是一家动作捕捉与模拟公司。过去10年间,Thomas先生担任DemeRx, Inc.的代理首席财务官(从2010年到2011年);担任MRI干预公司(MRI Interventions, Inc.)的首席财务官(从1998年到2010年),担任MiMedx Group, Inc. 的首席财务官(从2007年到2008年),并担任DARA BioSciences的首席财务官(从2003年到2009年);并担任MRI干预公司的董事(从2004年到2011年),于2012年担任DARA BioSciences的董事。在这之前,Thomas先生还担任沃克中学(Walker School)的理事,随后担任财务委员会主席, 这是一家私人的从学前班到12学级的小学(从1999年到2012年)。Thomas先生是一位注册会计师,并毕业于弗吉尼亚大学(University of Virginia)麦金太尔商学院(McIntire School of Commerce),于1975年以优异的成绩获得商业理学学士学位。
John C. Thomas, Jr. will be a director upon the completion of the Corporate Conversion. Since 2018 Mr. Thomas has served as the Chief Financial Officer and Secretary of SmartPharm Therapeutics, Inc, a genetic research and development company. In late 2017 Mr. Thomas rejoined DemeRx, Inc., a privately held company developing non-additive treatments for drug addiction, as the Chief Financial Officer after previously being the Chief Financial Officer from 2010 to 2013. Since April 2014 Mr. Thomas has served as a director of NantKwest, Inc. Nasdaq: NK and is chairperson of the audit committee and a member of the compensation committee. From 2001 until 2018 Mr. Thomas served as Chief Financial Officer and Secretary, and from 2001 to 2016 as a director of CorMatrix Cardiovascular, a privately held medical device company. He has also served as Chief Financial Officer, Secretary, and Director of Motion Reality, Inc., a motion capture and simulation company, since 1991. From 2012 until 2019 Mr. Thomas served as a director of Novelion Therapeutics, Inc. (formerly QLT, Inc.), a public company focused on rare diseases and was the Chairperson of their Audit and Risk Committee and Nominating and Governance Committee. During the past ten years, Mr. Thomas served as acting Chief Financial Officer for DemeRx, Inc., MRI Interventions, Inc., MiMedx Group, Inc., and DARA BioSciences and as a director of MRI Interventions, Inc. Between 1999 and 2012 Mr. Thomas served as a Trustee and subsequently the Chairman of the Finance Committee of The Walker School, a private school. Mr. Thomas is a Certified Public Accountant and graduated from the University of Virginia, McIntire School of Commerce.

高管简历

中英对照 |  中文 |  英文
Jarrett Gorlin

Jarrett Gorlin,他曾担任公司的首席执行官、总裁,以及董事(2013年11月以来)。加入公司之前,他曾担任Judicial Correction Services公司(JCS,全国最大的私人缓刑服务供应商,他于2001年合伙创建的公司)的总裁。他于2011年成功地达成JCS公司出售给Correctional Healthcare Companies (“CHC”),此后继续担任JCS公司的总裁。在他的领导下,JCS公司促成了INC。2010年、2011年和2012年的美国增长最快的公司的杂志名单。他的职业生涯始于16岁时成为最年轻的额定商业直升机飞行员,以及格鲁吉亚亚特兰大富尔顿县警长办公室的首席飞行员。他曾担任富尔顿县警长办公室的船长和指挥官(从1996年到现在)。他继续通过执法服务社区,作为储备单位的指挥官,负责监督法庭、监狱和保证部门的90名副行政长官。他也担任亚特兰大地区许多民选官员(包括富尔顿和格鲁吉亚克莱顿县的治安官)的政治顾问和顾问。他也曾任职于乔治亚州的前州长罗伊·巴恩斯的竞选财务委员会。


Jarrett Gorlin has served as the Chief Executive Officer, President, and a Director of the Company since November, 2013. Prior to joining the Company, Mr. Gorlin served as the President of Judicial Correction Services, Inc. “JCS”, the largest provider of private probation services in the country, which he co-founded in 2001. In 2011 he successfully negotiated the sale of JCS to Correctional Healthcare Companies (“CHC”), after which he has continued to serve as the President of JCS. Under Mr. Gorlin’s leadership, JCS made INC. Magazine’s list of the Fastest Growing Companies in America in 2010 2011 and 2012. Mr. Gorlin began his career by becoming the youngest rated commercial helicopter pilot at the age of 16 and becoming the chief pilot for the Fulton County Sheriff’s Office in Atlanta, Georgia. Mr. Gorlin has served a Captain and Commander at the Fulton County Sheriff’s Office where he has worked from 1996 to present. He continues to serve his community through law enforcement as the commander of a reserve unit overseeing 90 deputy sheriffs, who work in the courts, jail and warrant divisions. Mr. Gorlin also serves as a political advisor and consultant to many elected officials in the Atlanta area, including the current sitting Sheriff of Fulton and Clayton County, Georgia. He has also served on the campaign finance committeefor the former Governor of Georgia Roy Barnes.
Jarrett Gorlin,他曾担任公司的首席执行官、总裁,以及董事(2013年11月以来)。加入公司之前,他曾担任Judicial Correction Services公司(JCS,全国最大的私人缓刑服务供应商,他于2001年合伙创建的公司)的总裁。他于2011年成功地达成JCS公司出售给Correctional Healthcare Companies (“CHC”),此后继续担任JCS公司的总裁。在他的领导下,JCS公司促成了INC。2010年、2011年和2012年的美国增长最快的公司的杂志名单。他的职业生涯始于16岁时成为最年轻的额定商业直升机飞行员,以及格鲁吉亚亚特兰大富尔顿县警长办公室的首席飞行员。他曾担任富尔顿县警长办公室的船长和指挥官(从1996年到现在)。他继续通过执法服务社区,作为储备单位的指挥官,负责监督法庭、监狱和保证部门的90名副行政长官。他也担任亚特兰大地区许多民选官员(包括富尔顿和格鲁吉亚克莱顿县的治安官)的政治顾问和顾问。他也曾任职于乔治亚州的前州长罗伊·巴恩斯的竞选财务委员会。
Jarrett Gorlin has served as the Chief Executive Officer, President, and a Director of the Company since November, 2013. Prior to joining the Company, Mr. Gorlin served as the President of Judicial Correction Services, Inc. “JCS”, the largest provider of private probation services in the country, which he co-founded in 2001. In 2011 he successfully negotiated the sale of JCS to Correctional Healthcare Companies (“CHC”), after which he has continued to serve as the President of JCS. Under Mr. Gorlin’s leadership, JCS made INC. Magazine’s list of the Fastest Growing Companies in America in 2010 2011 and 2012. Mr. Gorlin began his career by becoming the youngest rated commercial helicopter pilot at the age of 16 and becoming the chief pilot for the Fulton County Sheriff’s Office in Atlanta, Georgia. Mr. Gorlin has served a Captain and Commander at the Fulton County Sheriff’s Office where he has worked from 1996 to present. He continues to serve his community through law enforcement as the commander of a reserve unit overseeing 90 deputy sheriffs, who work in the courts, jail and warrant divisions. Mr. Gorlin also serves as a political advisor and consultant to many elected officials in the Atlanta area, including the current sitting Sheriff of Fulton and Clayton County, Georgia. He has also served on the campaign finance committeefor the former Governor of Georgia Roy Barnes.
Patrick Kullmann

Patrick Kullmann,2013年9月以来,她一直是我们的首席营运官。他曾一直担任Streamline公司(医疗技术公司)的合同首席执行官(2012年以来)。他也是CG3 Consulting公司(全球医疗技术咨询公司,位于明尼阿波利斯、波士顿和圣地亚哥,他于2008年创立的公司)的创始人。CG3 Consulting公司为医疗保健、科学和技术行业的客户提供咨询服务。创立CG3 Consulting公司之前,他曾担任 Medtronic公司的高级董事,负责他们23亿美元的心血管部门。他的职业生涯始于担任德克萨斯州的休斯顿医学中心外科销售代表。他曾担任Boston Scientific公司、Baxter公司、Johnson & Johnson公司,以及4家初创医疗器械公司(两家曾成功总价值220美元流动性事件)的高级市场营销、市场开发和销售领导职位。他毕业于Northern Michigan University,并获得California Coastal University的工商管理硕士学位。


Patrick Kullmann has been our President and Chief Operating Officer since September, 2013. Mr. Kullmann has served in a contract capacity as the Chief Executive Officer of Streamline, Inc., a medical technology company since 2012. He is also the Founder of CG3 Consulting, LLC, a global medical technology advisory firm in Minneapolis, Boston and San Diego which he founded in 2008. CG3 Consulting provides consulting services to clients in the healthcare, scientific and technology industries. Prior to establishing CG3 Consulting, Mr. Kullmann was a senior director at Medtronic in their $2.3 billion Cardiovascular Division. He started his career working as a surgical sales representative in the Texas Medical Center in Houston. Mr. Kullmann has served in senior marketing, market development and sales leadership positions at Boston Scientific, Baxter, Johnson & Johnson, and four start-up medical device companies - two of which had successful liquidity events for a combined value of $220m. He is a graduate of Northern Michigan University, and has an MBA from California Coastal University.
Patrick Kullmann,2013年9月以来,她一直是我们的首席营运官。他曾一直担任Streamline公司(医疗技术公司)的合同首席执行官(2012年以来)。他也是CG3 Consulting公司(全球医疗技术咨询公司,位于明尼阿波利斯、波士顿和圣地亚哥,他于2008年创立的公司)的创始人。CG3 Consulting公司为医疗保健、科学和技术行业的客户提供咨询服务。创立CG3 Consulting公司之前,他曾担任 Medtronic公司的高级董事,负责他们23亿美元的心血管部门。他的职业生涯始于担任德克萨斯州的休斯顿医学中心外科销售代表。他曾担任Boston Scientific公司、Baxter公司、Johnson & Johnson公司,以及4家初创医疗器械公司(两家曾成功总价值220美元流动性事件)的高级市场营销、市场开发和销售领导职位。他毕业于Northern Michigan University,并获得California Coastal University的工商管理硕士学位。
Patrick Kullmann has been our President and Chief Operating Officer since September, 2013. Mr. Kullmann has served in a contract capacity as the Chief Executive Officer of Streamline, Inc., a medical technology company since 2012. He is also the Founder of CG3 Consulting, LLC, a global medical technology advisory firm in Minneapolis, Boston and San Diego which he founded in 2008. CG3 Consulting provides consulting services to clients in the healthcare, scientific and technology industries. Prior to establishing CG3 Consulting, Mr. Kullmann was a senior director at Medtronic in their $2.3 billion Cardiovascular Division. He started his career working as a surgical sales representative in the Texas Medical Center in Houston. Mr. Kullmann has served in senior marketing, market development and sales leadership positions at Boston Scientific, Baxter, Johnson & Johnson, and four start-up medical device companies - two of which had successful liquidity events for a combined value of $220m. He is a graduate of Northern Michigan University, and has an MBA from California Coastal University.
Charles Farrahar

Charles Farrahar,2013年9月以来,他一直担任我们的首席财务官、秘书兼财务主管。他是注册会计师,拥有30年的公共、私人和非营利部门的管理财务、管理、人力资源和会计经验。他曾担任公开交易的Credit Depot Corp的首席财务官(从1997年到1998年),但也专注于私人控股早期阶段公司(包括三家公司,致力于研发各种医疗技术)。他曾担任Judicial Correction Services公司的首席财务官(从2003年到2012年),并帮助它从25成长到400 +员工组织。


Charles Farrahar has served as our Chief Financial Officer, Secretary and Treasurer since September 2013. He is a certified public accountant with 30 years of managerial finance, administration, human resource and accounting experience in the public, private and non-profit sectors. He was CFO for publicly traded Credit Depot Corp 1997 -1998 but has since focused on privately held early stage companies, including three companies formed to develop various medical technologies. He served as CFO of Judicial Correction Services from 2003 - 2012 helping it grow from a 25 to 400+ employee organization.
Charles Farrahar,2013年9月以来,他一直担任我们的首席财务官、秘书兼财务主管。他是注册会计师,拥有30年的公共、私人和非营利部门的管理财务、管理、人力资源和会计经验。他曾担任公开交易的Credit Depot Corp的首席财务官(从1997年到1998年),但也专注于私人控股早期阶段公司(包括三家公司,致力于研发各种医疗技术)。他曾担任Judicial Correction Services公司的首席财务官(从2003年到2012年),并帮助它从25成长到400 +员工组织。
Charles Farrahar has served as our Chief Financial Officer, Secretary and Treasurer since September 2013. He is a certified public accountant with 30 years of managerial finance, administration, human resource and accounting experience in the public, private and non-profit sectors. He was CFO for publicly traded Credit Depot Corp 1997 -1998 but has since focused on privately held early stage companies, including three companies formed to develop various medical technologies. He served as CFO of Judicial Correction Services from 2003 - 2012 helping it grow from a 25 to 400+ employee organization.
Dennis Moon

Dennis Moon,她一直担任我们的高级副总裁(2013年11月以来)。加入公司之前,他曾担任Judicial Correction Services公司的首席运营官(从2006年到2013年),监督JCS社会监督部门(监督超过50000活跃在美国东南部的缓刑犯)的日常操作。他曾负责管理超过400名员工,以及每年超过180万的金融交易。他毕业于the University of Central Florida,拥有心理学学位,专注于毒品和酒精成瘾。高中毕业后,他加入美国军队,在那里他服役8年,担任情报分析师,并因各种服务获得了无数的奖项和奖牌。


Dennis Moon has served as our Senior Vice President since November, 2013. Prior to joining the Company, he was the Chief Operations Officer for Judicial Correction Services 2006 - 2013 supervising the day to day operations of the JCS community supervision division, which supervised over 50000 active probationers throughout the southeast United States. He was responsible for supervision of over 400 employees and over 1.8 million financial transactions per year. Dennis is a graduate of the University of Central Florida and has a degree in Psychology with an emphasis on Drug and Alcohol addiction. After graduating high school, he joined the United States Army where he served for eight years as an Intelligence Analyst and received numerous awards and medals for various services.
Dennis Moon,她一直担任我们的高级副总裁(2013年11月以来)。加入公司之前,他曾担任Judicial Correction Services公司的首席运营官(从2006年到2013年),监督JCS社会监督部门(监督超过50000活跃在美国东南部的缓刑犯)的日常操作。他曾负责管理超过400名员工,以及每年超过180万的金融交易。他毕业于the University of Central Florida,拥有心理学学位,专注于毒品和酒精成瘾。高中毕业后,他加入美国军队,在那里他服役8年,担任情报分析师,并因各种服务获得了无数的奖项和奖牌。
Dennis Moon has served as our Senior Vice President since November, 2013. Prior to joining the Company, he was the Chief Operations Officer for Judicial Correction Services 2006 - 2013 supervising the day to day operations of the JCS community supervision division, which supervised over 50000 active probationers throughout the southeast United States. He was responsible for supervision of over 400 employees and over 1.8 million financial transactions per year. Dennis is a graduate of the University of Central Florida and has a degree in Psychology with an emphasis on Drug and Alcohol addiction. After graduating high school, he joined the United States Army where he served for eight years as an Intelligence Analyst and received numerous awards and medals for various services.
Jeffery Wright

Jeffery Wright是一名注册会计师,2015年1月从总监升值为首席财务官。2014年12月加入公司,在此之前Wright担任Ernst & Young的保险服务分部审计高级官员,帮助管理年收入从20亿美元到100亿美元的公开上市公司的审计。他还拥有中型(年收入为200万美元到2亿美元)私营公司审计经验,其中涉及多个行业和多个会计公司。开始公共会计职业生涯之前,Wright在Reliance Trust Company退休信托服务部门担任贸易分析师,管理机构交易,处理与National Securities Clearing Corporation的互惠基金交易问题。Wright持有Georgia State University Robinson College of Business专业会计硕士学位和工商管理学士学位;是Georgia Society of Certified Public Accountants成员。


Jeffery Wright is a Certified Public Accountant and has served as our Chief Financial Officer and Treasurer since January 2015. Prior to joining the Company in December, 2014 Mr. Wright was an audit senior at Ernst & Young within the Assurance Services division, where he had an opportunity to help manage audits of large $2 billion to $10 billion annual revenue publicly-traded companies. He also has experience auditing medium size ($2 million - $200 million annual revenue) privately-held companies in multiple industries with other accounting firms. Prior to his career in public accounting, Mr. Wright worked as a trading analyst in the retirement trust services department at Reliance Trust Company, managing the institutional trading desk to settle mutual fund transactions with the National Securities Clearing Corporation. Mr. Wright holds Master of Professional Accountancy and Bachelor of Business Administration degrees from the Georgia State University Robinson College of Business and is a member of the Georgia Society of Certified Public Accountants.
Jeffery Wright是一名注册会计师,2015年1月从总监升值为首席财务官。2014年12月加入公司,在此之前Wright担任Ernst & Young的保险服务分部审计高级官员,帮助管理年收入从20亿美元到100亿美元的公开上市公司的审计。他还拥有中型(年收入为200万美元到2亿美元)私营公司审计经验,其中涉及多个行业和多个会计公司。开始公共会计职业生涯之前,Wright在Reliance Trust Company退休信托服务部门担任贸易分析师,管理机构交易,处理与National Securities Clearing Corporation的互惠基金交易问题。Wright持有Georgia State University Robinson College of Business专业会计硕士学位和工商管理学士学位;是Georgia Society of Certified Public Accountants成员。
Jeffery Wright is a Certified Public Accountant and has served as our Chief Financial Officer and Treasurer since January 2015. Prior to joining the Company in December, 2014 Mr. Wright was an audit senior at Ernst & Young within the Assurance Services division, where he had an opportunity to help manage audits of large $2 billion to $10 billion annual revenue publicly-traded companies. He also has experience auditing medium size ($2 million - $200 million annual revenue) privately-held companies in multiple industries with other accounting firms. Prior to his career in public accounting, Mr. Wright worked as a trading analyst in the retirement trust services department at Reliance Trust Company, managing the institutional trading desk to settle mutual fund transactions with the National Securities Clearing Corporation. Mr. Wright holds Master of Professional Accountancy and Bachelor of Business Administration degrees from the Georgia State University Robinson College of Business and is a member of the Georgia Society of Certified Public Accountants.
Manfred Sablowski

Manfred Sablowski是一位商业专业人士,在医疗技术行业拥有超过20年的高级管理经验,他在管理和发展几家非常成功的公司方面发挥了重要作用。他曾担任多个执行级别的职务,如欧洲Valleylab/Pfizer公司的总经理、欧洲销售与市场营销Dornier Medizin Technik公司的副总裁、全球销售与市场营销Bovie Medical公司的副总裁。他还担任Trod Medical的董事会成员和Vice President/首席运营官,这是一家成功的风险投资支持的初创公司,他从公司成立之初就参与其中。他是FMS Medtech Consulting(咨询公司,专注于欧洲和美国医疗行业国际业务的战略规划)的负责人。Sablowski先生拥有理学学士学位,化学工程师文凭,并在德国获得工商管理硕士学位。


Manfred Sablowski is a business professional with over 20 years of senior management experience in the medical technology industry, where he has been instrumental in managing and growing several highly successful companies. He has held several executive level positions such as General Manager at Valleylab/Pfizer, Europe; VP Sales and Marketing Dornier Medizin Technik, Europe; VP Sales and Marketing Bovie Medical-Worldwide. He also served as Board Member and Vice President/COO for Trod Medical, a successful venture backed start-up, in which he was involved from its inception. He is the principal of FMS MedTech Consulting, a consulting firm focusing on strategic planning for the international businesses in the medical industry Europe and U.S.. Mr. Sablowski holds a bachelor of science, a diploma as chemical engineer and earned an MBA in Germany.
Manfred Sablowski是一位商业专业人士,在医疗技术行业拥有超过20年的高级管理经验,他在管理和发展几家非常成功的公司方面发挥了重要作用。他曾担任多个执行级别的职务,如欧洲Valleylab/Pfizer公司的总经理、欧洲销售与市场营销Dornier Medizin Technik公司的副总裁、全球销售与市场营销Bovie Medical公司的副总裁。他还担任Trod Medical的董事会成员和Vice President/首席运营官,这是一家成功的风险投资支持的初创公司,他从公司成立之初就参与其中。他是FMS Medtech Consulting(咨询公司,专注于欧洲和美国医疗行业国际业务的战略规划)的负责人。Sablowski先生拥有理学学士学位,化学工程师文凭,并在德国获得工商管理硕士学位。
Manfred Sablowski is a business professional with over 20 years of senior management experience in the medical technology industry, where he has been instrumental in managing and growing several highly successful companies. He has held several executive level positions such as General Manager at Valleylab/Pfizer, Europe; VP Sales and Marketing Dornier Medizin Technik, Europe; VP Sales and Marketing Bovie Medical-Worldwide. He also served as Board Member and Vice President/COO for Trod Medical, a successful venture backed start-up, in which he was involved from its inception. He is the principal of FMS MedTech Consulting, a consulting firm focusing on strategic planning for the international businesses in the medical industry Europe and U.S.. Mr. Sablowski holds a bachelor of science, a diploma as chemical engineer and earned an MBA in Germany.